1.61
price up icon1.90%   0.03
 
loading
前日終値:
$1.58
開ける:
$1.58
24時間の取引高:
765.00K
Relative Volume:
0.68
時価総額:
$112.30M
収益:
$139.77M
当期純損益:
$-97.62M
株価収益率:
-1.019
EPS:
-1.58
ネットキャッシュフロー:
$-61.71M
1週間 パフォーマンス:
+10.27%
1か月 パフォーマンス:
-5.85%
6か月 パフォーマンス:
-49.37%
1年 パフォーマンス:
-65.38%
1日の値動き範囲:
Value
$1.52
$1.62
1週間の範囲:
Value
$1.335
$1.65
52週間の値動き範囲:
Value
$0.9897
$5.77

Macrogenics Inc Stock (MGNX) Company Profile

Name
名前
Macrogenics Inc
Name
セクター
Healthcare (1164)
Name
電話
301-251-5172
Name
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
職員
341
Name
Twitter
@macrogenics
Name
次回の収益日
2025-03-07
Name
最新のSEC提出書
Name
MGNX's Discussions on Twitter

MGNX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MGNX
Macrogenics Inc
1.61 112.30M 139.77M -97.62M -61.71M -1.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.85 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
314.94 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.24 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
250.30 28.51B 3.81B -644.79M -669.77M -6.24

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-07 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 ダウングレード BTIG Research Buy → Neutral
2024-07-31 ダウングレード B. Riley Securities Buy → Neutral
2024-07-31 ダウングレード Guggenheim Buy → Neutral
2024-05-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-05-10 ダウングレード Stifel Buy → Hold
2024-05-10 ダウングレード TD Cowen Buy → Hold
2024-04-26 開始されました B. Riley Securities Buy
2024-04-09 アップグレード TD Cowen Hold → Buy
2024-03-04 繰り返されました BTIG Research Buy
2024-02-14 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-20 アップグレード Citigroup Neutral → Buy
2023-11-07 アップグレード Guggenheim Neutral → Buy
2023-03-17 ダウングレード Guggenheim Buy → Neutral
2022-11-22 ダウングレード Cowen Outperform → Market Perform
2022-11-14 アップグレード BMO Capital Markets Market Perform → Outperform
2022-07-18 ダウングレード SMBC Nikko Outperform → Neutral
2022-07-11 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-05-04 ダウングレード Guggenheim Buy → Neutral
2022-02-28 アップグレード Citigroup Neutral → Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-02-04 開始されました SMBC Nikko Outperform
2021-11-17 再開されました Guggenheim Buy
2021-10-19 開始されました JMP Securities Mkt Outperform
2021-10-15 再開されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-03-12 アップグレード Barclays Underweight → Overweight
2020-12-22 再開されました H.C. Wainwright Buy
2020-08-03 ダウングレード Citigroup Buy → Neutral
2020-06-01 アップグレード Guggenheim Neutral → Buy
2020-05-26 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Underweight
2019-12-19 開始されました Cantor Fitzgerald Overweight
2019-12-18 開始されました Cantor Fitzgerald Overweight
2019-11-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-11-20 再開されました Guggenheim Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Guggenheim Neutral
2019-02-07 アップグレード Citigroup Sell → Buy
2019-02-07 ダウングレード Wedbush Outperform → Neutral
2019-02-06 アップグレード Raymond James Underperform → Mkt Perform
2019-02-04 ダウングレード Citigroup Neutral → Sell
2018-12-10 ダウングレード Raymond James Outperform → Underperform
2018-09-10 再開されました BTIG Research Buy
2018-05-31 開始されました Evercore ISI Outperform
2018-03-05 開始されました H.C. Wainwright Buy
2017-03-31 開始されました Raymond James Outperform
すべてを表示

Macrogenics Inc (MGNX) 最新ニュース

pulisher
Jun 18, 2025

A Closer Look at Macrogenics Inc (MGNX) Stock Gains - investchronicle.com

Jun 18, 2025
pulisher
Jun 18, 2025

MacroGenics (NASDAQ:MGNX) Shares Pass Below Two Hundred Day Moving Average – Time to Sell? - Defense World

Jun 18, 2025
pulisher
Jun 14, 2025

MacroGenics’ SWOT analysis: biotech firm’s stock faces pivotal year ahead By Investing.com - Investing.com India

Jun 14, 2025
pulisher
Jun 14, 2025

MacroGenics’ SWOT analysis: biotech firm’s stock faces pivotal year ahead - Investing.com

Jun 14, 2025
pulisher
Jun 14, 2025

MacroGenics secures $70M from Sagard in royalty deal By Investing.com - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 11, 2025

MacroGenics: Working On That Road To Recovery (NASDAQ:MGNX) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 11, 2025

MacroGenics lands $70M 'infusion of cash' to advance clinical programs - The Business Journals

Jun 11, 2025
pulisher
Jun 11, 2025

MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Jun 11, 2025
pulisher
Jun 11, 2025

Traders Buy High Volume of MacroGenics Call Options (NASDAQ:MGNX) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

MacroGenics (MGNX) Secures $70M Upfront Payment in Royalty Deal - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics signs financial deal with Sagard for retifanlimab - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics, Inc. and Sagard Healthcare Partners Enter into ZYNYZ Royalty Purchase Agreement - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics, Sagard Sign Zynyz Royalty Purchase Deal - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics at Goldman Sachs Conference: Strategic Pipeline Expansion - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

United Natural Foods, Insmed, MacroGenics - TradingView

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : MacroGenics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics at Goldman Sachs Conference: Strategic Pipeline Expansion By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Roy - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics, Inc. (NASDAQ:MGNX) Shares Bought by Bank of America Corp DE - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics secures $70M from Sagard in royalty deal - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics, Sagard Healthcare enter into ZYNYZ royalty purchase - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics stock soars on royalty deal with Sagard By Investing.com - Investing.com Nigeria

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics stock soars on royalty deal with Sagard - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics Enters Royalty Purchase Agreement with Sagard - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics (MGNX) Secures $70 Million Through Royalty Agreement | MGNX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement - GlobeNewswire

Jun 10, 2025
pulisher
Jun 09, 2025

Would I Choose Macrogenics Inc (NASDAQ: MGNX) Stock At Any Point In Time? - Stocksregister

Jun 09, 2025
pulisher
Jun 08, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics LawsuitMGNX - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 08, 2025

MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug TrialHagens Berman - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 07, 2025

MacroGenics (NASDAQ:MGNX) Upgraded by Wall Street Zen to “Hold” Rating - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Sells 26,544 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Brokerages Set MacroGenics, Inc. (NASDAQ:MGNX) PT at $5.71 - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

HAGENS BERMAN, SHAREHOLDER ADVOCATES, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 6-Day Application Deadline is Approaching - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 5-Day Application Deadline is Approaching in Securities Class Action - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

MacroGenics to Present at the Goldman Sachs 46th Annual Global H - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 | MGNX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

MacroGenics Executives Set for Major Goldman Sachs Healthcare Conference Presentation: Watch Live - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 – MGNX - ACCESS Newswire

Jun 03, 2025
pulisher
May 30, 2025

MacroGenics (NASDAQ:MGNX) Upgraded to Hold at Wall Street Zen - Defense World

May 30, 2025
pulisher
May 29, 2025

Levi & Korsinsky Notifies Shareholders of MacroGenics, Inc.(MGNX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

May 29, 2025
pulisher
May 27, 2025

MacroGenics’ SWOT analysis: biotech firm’s stock faces pipeline challenges By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

MacroGenics’ SWOT analysis: biotech firm’s stock faces pipeline challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

Lazard Asset Management LLC Purchases New Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 27, 2025
pulisher
May 27, 2025

Northern Trust Corp Has $1.76 Million Stock Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 27, 2025
pulisher
May 26, 2025

Millennium Management LLC Sells 671,179 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 26, 2025
pulisher
May 23, 2025

Q2 Earnings Forecast for MacroGenics Issued By B. Riley - Defense World

May 23, 2025
pulisher
May 22, 2025

MacroGenics Holds Annual Stockholders Meeting on May 21 - TipRanks

May 22, 2025
pulisher
May 22, 2025

B. Riley Issues Pessimistic Forecast for MacroGenics (NASDAQ:MGNX) Stock Price - Defense World

May 22, 2025
pulisher
May 22, 2025

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

Analyst Forecasts For MacroGenics, Inc. (NASDAQ:MGNX) Are Surging Higher - simplywall.st

May 21, 2025

Macrogenics Inc (MGNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Macrogenics Inc (MGNX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Karrels James
SVP, CFO and Secretary
Feb 15 '25
Option Exercise
0.00
14,998
0
192,591
Koenig Scott
President and CEO
Feb 15 '25
Option Exercise
0.00
42,329
0
777,415
Peters Jeffrey Stuart
Senior VP and General Counsel
Feb 15 '25
Option Exercise
0.00
13,332
0
18,858
Risser Eric Blasius
Chief Operating Officer
Feb 15 '25
Option Exercise
0.00
16,665
0
62,422
Smith Beth Ann
VP, Controller & Treasurer
Feb 15 '25
Option Exercise
0.00
1,095
0
9,955
Smith Beth Ann
VP, Controller & Treasurer
Feb 15 '25
Sale
2.56
423
1,083
9,532
Spitznagel Thomas
Sr VP, Technical Ops
Feb 15 '25
Option Exercise
0.00
13,332
0
26,922
Eck Stephen L.
Chief Medical Officer
Feb 15 '25
Option Exercise
0.00
16,665
0
34,319
Eck Stephen L.
Chief Medical Officer
Feb 08 '25
Option Exercise
0.00
11,168
0
20,966
$21.40
price down icon 2.10%
$35.84
price down icon 0.78%
$25.00
price down icon 3.40%
$98.18
price up icon 1.57%
$112.89
price down icon 0.90%
biotechnology ONC
$250.30
price down icon 1.22%
大文字化:     |  ボリューム (24 時間):